Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Post by wildbird1on Aug 16, 2018 9:20am
185 Views
Post# 28470845

'' Billion dollar Potential ''

'' Billion dollar Potential ''As I have mentionned in one of my last post '' At this point in time it doesn't matter how much profits is generated in Q2, what does matter is that the billing process and the test distribution network work in unison.

1: We must remember that the billing process was restructured and restarted only a few weeks before the financial (May 16, 2018).
2: Most of the tests are payable after 45 days.
3: You can't expect to have big results in such a short time ( would have been nice, unfortunately not enough time).

Give the billing process and test distribution network time to be fully functional...results will come in due time.

Billion Dollar Potential...
Take the time to read LifeX web site...
In the LifeX porfolio section LifeX said (Quote): '' Companies in the LifeX Portfolio have two things in common...Stand out Innovation and billion dollar Potential (End Of Quote).

Genenews has innovative technologies and billion dollar potential.





Bullboard Posts